BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20635020)

  • 1. Ceftriaxone induced acute multi-organ failure syndrome in a Saudi boy with sickle cell disease.
    Al-Hawsawi ZM; Turkistani WA; Al-Aidaros MA; Al-Harbi DL
    Saudi Med J; 2010 Jul; 31(7):826-8. PubMed ID: 20635020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone induced acute multi-organ failure syndrome in a Saudi boy with sickle cell disease.
    Al-Mendalawi MD
    Saudi Med J; 2011 Mar; 32(3):320. PubMed ID: 21384076
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.
    Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange in critically ill patients with sickle cell disease.
    Boga C; Kozanoglu I; Ozdogu H; Ozyurek E
    Transfus Apher Sci; 2007 Aug; 37(1):17-22. PubMed ID: 17707694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiorgan dysfunction syndrome in sickle cell disease.
    Hiran S
    J Assoc Physicians India; 2005 Jan; 53():19-22. PubMed ID: 15857006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute complications in sickle cell disease].
    Habibi A; Bachir D; Godeau B
    Rev Prat; 2004 Sep; 54(14):1548-56. PubMed ID: 15558964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ceftriaxone-induced immune haemolytic anaemia and multi-organ failure].
    Mulkens CE; van Lochem EG; Folman CC; van der Spek E; van Leeuwen HJ
    Ned Tijdschr Geneeskd; 2015; 159():A8054. PubMed ID: 25714764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hemolytic crisis after ceftriaxone administration.
    Goyal M; Donoghue A; Schwab S; Hasbrouck N; Khojasteh S; Osterhoudt K
    Pediatr Emerg Care; 2011 Apr; 27(4):322-3. PubMed ID: 21467885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea in sickle cell disease patients from Eastern Saudi Arabia.
    Al-Jam'a AH; Al-Dabbous IA
    Saudi Med J; 2002 Mar; 23(3):277-81. PubMed ID: 11938415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbital compression syndrome in sickle cell crisis.
    Mueller EB; Niethammer K; Rees D; Partsch CJ
    Klin Padiatr; 2009 Sep; 221(5):308-9. PubMed ID: 19707994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone induced hemolysis complicated by acute renal failure.
    Kapur G; Valentini RP; Mattoo TK; Warrier I; Imam AA
    Pediatr Blood Cancer; 2008 Jan; 50(1):139-42. PubMed ID: 16602117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe immune haemolytic anaemia due to ceftriaxone in a patient with congenital nephrotic syndrome.
    Reis Boto ML; Sandes AR; Brites A; Silva S; Stone R; Almeida M
    Acta Paediatr; 2011 Oct; 100(10):e191-3. PubMed ID: 21450013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia.
    Bernini JC; Mustafa MM; Sutor LJ; Buchanan GR
    J Pediatr; 1995 May; 126(5 Pt 1):813-5. PubMed ID: 7752012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease.
    Wilimas JA; Flynn PM; Harris S; Day SW; Smith R; Chesney PJ; Rodman JH; Eguiguren JM; Fairclough DL; Wang WC
    N Engl J Med; 1993 Aug; 329(7):472-6. PubMed ID: 8332152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease.
    Bell MJ; Stockwell DC; Luban NL; Shirey RS; Shaak L; Ness PM; Wong EC
    Pediatr Crit Care Med; 2005 May; 6(3):363-6. PubMed ID: 15857541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N
    Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of hydroxyurea on hemoglobin S].
    Torres AF; Eberle SE; Sciuccati G; Bonduel M
    Medicina (B Aires); 2003; 63(2):140-2. PubMed ID: 12793083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone-induced hemolysis in a child with Lyme arthritis: a case for antimicrobial stewardship.
    Boggs SR; Cunnion KM; Raafat RH
    Pediatrics; 2011 Nov; 128(5):e1289-92. PubMed ID: 21969285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine abuse complicating acute painful episodes in sickle cell disease.
    Boulmay B; Lottenberg R
    South Med J; 2009 Jan; 102(1):87-8. PubMed ID: 19077772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.